← Back to Clinical Trials
Recruiting NCT06991543

NCT06991543 Structural Heat Adaptation and Education in Urban Setting

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06991543
Status Recruiting
Phase
Sponsor Aga Khan University
Condition Heat Illness
Study Type INTERVENTIONAL
Enrollment 7,128 participants
Start Date 2026-01-01
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Community education and awareness, and personal lifestyle and cooling behavior modificationParticipatory local structural and environmental heat mitigation solutions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 7,128 participants in total. It began in 2026-01-01 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to understand whether simple, low-cost interventions, such as improved home cooling, practical advice, and minor home modifications, can help protect people's health and improve quality of life during periods of extreme heat in densely populated, low-income neighborhoods of Karachi, Pakistan. Key Questions the Study Seeks to Answer: 1. Can these interventions reduce heat-related health problems such as dizziness, headaches, and heatstroke and improve the quality of life? 2. Can they lower indoor temperatures and improve sleep quality, comfort, and daily functioning? To answer these questions, researchers will compare communities where families receive heat-related support and information with similar communities that do not, to assess any differences in health and well-being. What Participants Can Expect: * Answer questions about their health, living conditions, and how they cope with heat * Have small temperature sensors placed inside their homes * Some participants may wear a lightweight wristband that tracks sleep and heart rate * In selected households, cooling improvements will be made, such as adding shade, applying reflective roof paint, or enhancing airflow Purpose: This study seeks to identify affordable and effective strategies to help families stay safe during extreme heat, and to use these insights to support other vulnerable communities facing similar challenges.

Eligibility Criteria

Inclusion Criteria: * All households within the selected clusters who provide consent. Exclusion Criteria: * Households planning to move away from the study site within the next 6 months * Individuals with severe mental or physical health conditions that preclude participation

Contact & Investigator

Central Contact

Jai K Das

✉ jai.das@aku.edu

📞 +922134864717

Principal Investigator

jai K Das

PRINCIPAL INVESTIGATOR

Institute for global health and development, Aga Khan University.

Frequently Asked Questions

Who can join the NCT06991543 clinical trial?

This trial is open to participants of all sexes, studying Heat Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06991543 currently recruiting?

Yes, NCT06991543 is actively recruiting participants. Contact the research team at jai.das@aku.edu for enrollment information.

Where is the NCT06991543 trial being conducted?

This trial is being conducted at Karachi, Pakistan.

Who is sponsoring the NCT06991543 clinical trial?

NCT06991543 is sponsored by Aga Khan University. The principal investigator is jai K Das at Institute for global health and development, Aga Khan University.. The trial plans to enroll 7,128 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology